Actively Recruiting
Clinical Efficacy of Ustekinumab in Crohn's Disease
Led by Kazakhstan Scientific Society for Study of intestine diseases · Updated on 2024-07-26
150
Participants Needed
4
Research Sites
126 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Clinical Efficacy of Ustekinumab in Crohn's Disease: an Observational Study With Retrospective and Prospective Components.
CONDITIONS
Official Title
Clinical Efficacy of Ustekinumab in Crohn's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years and older
- Patients who were first prescribed Ustekinumab between January 1 and December 31, 2024
- Patients who provided written informed consent to participate in the study
You will not qualify if you...
- Contraindications to Ustekinumab as per current instructions
- Clinically significant active infection including active tuberculosis or viral hepatitis
- Pregnancy and lactation
- History of psychiatric disorders interfering with study compliance
- Ulcerative colitis
- Malignant gastrointestinal diseases currently or in history
- Decompensated chronic diseases of liver, kidneys, cardiovascular system, systemic vasculitis, diabetes mellitus
- Alcohol or psychoactive drug abuse within 1 year before study start
- Participation in an interventional clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
NJSC "West Kazakhstan Marat Ospanov Medical University"
Aktobe, Kazakhstan
Actively Recruiting
2
Non-Profit Joint Stock Company "Kazakh National Medical University named after S.D. Asfendiyarov"
Almaty, Kazakhstan, 055990
Actively Recruiting
3
State-owned public enterprise with the right of economic management "Multidisciplinary City Hospital No. 1" of the Akimat of Astana
Astana, Kazakhstan
Actively Recruiting
4
State-owned public enterprise with the right of economic management "Regional Clinical Hospital" of the Health Department of the Turkestan Region
Shymkent, Kazakhstan
Actively Recruiting
Research Team
K
Kanat Khazhidinov
CONTACT
Y
Yekaterina Sakhabutdinova
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here